Heating the Heart Works Better than Drugs for Common Heart Rhythm Disorder
|
Tweet
|
|
Treating a common heart rhythm disorder by burning heart tissue with a catheter works dramatically better than drug treatments, a major international study has found.
One year after undergoing a treatment called catheter ablation, 75 percent of patients with an irregular heartbeat called atrial fibrillation were free of symptoms. By comparison, only 21 percent of those treated with drugs were symptom-free. Results were so convincing the trial was halted early.
The ablation group also scored significantly higher on a quality-of-life scale
The study included 159 patients at 19 centers, including 15 centers in the United States. Results were presented at the American Heart Association 2008 Scientific Sessions in New Orleans by lead researcher Dr. David Wilber, director of the Cardiovascular Institute at Loyola University Stritch School of Medicine in Maywood, Il.
Atrial fibrillation, often called A-Fib, is the most common form of irregular heartbeat. Electrical signals, which regulate the heartbeat, become erratic. Instead of beating regularly, the upper chambers of the heart quiver. Not all the blood gets pumped out, so clots can form. Atrial fibrillation can lead to strokes and heart failure.
A-Fib patient Robin Drabant, 34, of Hanover Park, Il., said the condition once “made me feel like I was 90 years old with a failing heart.” She was on a maximum dose of an A-Fib medication, which caused fatigue. Despite the drug, she still had episodes almost every day, lasting from 10 seconds to an hour or longer. “I would lose my breath and could feel my heart racing and fluttering,” she said.
Wilber performed a catheter ablation on Drabant last May, and she no longer has A-Fib episodes. “I had great results,” she said.
A-Fib symptoms include heart palpitations, dizziness, fatigue, shortness of breath and fainting. “A lot of people are disabled,” Wilber said. “They have no energy. They can’t work. They have a very poor quality of life.”
More than 2 million Americans have atrial fibrillation, and there are about 160,000 new cases each year. The number is increasing, due in part to the aging population and the obesity epidemic.
Drugs such as beta blockers and calcium channel blockers can slow the heart rate. Other drugs such as flecainide and propafenone can help maintain a normal rhythm. When drugs don’t work or produce unacceptable side effects, alternative treatments include a pacemaker, surgery and catheter ablation.
In the ablation procedure, an electrophysiologist destroys small areas of heart tissue that are responsible for the erratic electrical signals. A catheter (thin flexible tube) is guided through blood vessels to the heart. The tip of the catheter delivers radiofrequency energy that heats and destroys tissue. Possible adverse effects include irritation of the lining of the heart, fluid in the lungs or around the heart, bleeding, clots and stroke.
In the study, 103 patients with frequent episodes of atrial fibrillation were randomly assigned to undergo ablation and 56 similar patients were randomly assigned to receive drug therapy. All patients had experienced at least three episodes of atrial fibrillation during the previous six months and had failed at least one attempt to control the rhythm with drugs.
The study was funded by Biosense Webster, which makes the ThermoCool catheter used in the trial. Wilber is a consultant to the company.
The study was the largest to date to compare ablation to drug therapy for atrial fibrillation. Earlier studies involved single centers and smaller sample sizes, Wilber said. An additional study called CABANA id designed to determine whether ablation patients live longer than patients receiving medication. Researchers will follow about 3,000 patients for three years.
Based in the western suburbs of Chicago, Loyola University Health System is a quaternary care system with a 61-acre main medical center campus, the 36-acre Gottlieb Memorial Hospital campus and 25 primary and specialty care facilities in Cook, Will and DuPage counties. The medical center campus is conveniently located in Maywood, 13 miles west of the Chicago Loop and 8 miles east of Oak Brook, Ill. The heart of the medical center campus, Loyola University Hospital, is a 570-licensed bed facility. It houses a Level 1 Trauma Center, a Burn Center and the Ronald McDonald® Children’s Hospital of Loyola University Medical Center. Also on campus are the Cardinal Bernardin Cancer Center, Loyola Outpatient Center, Center for Heart & Vascular Medicine and Loyola Oral Health Center as well as the LUC Stritch School of Medicine, the LUC Marcella Niehoff School of Nursing and the Loyola Center for Health & Fitness. Loyola’s Gottlieb campus in Melrose Park includes the 250-bed community hospital, the Gottlieb Health & Fitness Center and the Marjorie G. Weinberg Cancer Care Center.
Source: Loyola University Health System
 |
 |
 |
 | ||
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
